Oruka Therapeutics (ORKA) Return on Capital Employed [ROCE] (2011 - 2024)
Oruka Therapeutics' Return on Capital Employed [ROCE] was -26.85% in Q2 2024, down 7.16 percentage points from -19.69% a year earlier and down 4.50 percentage points from the prior quarter.
Oruka Therapeutics (ORKA) Return on Capital Employed [ROCE] (2011 - 2024) Analysis & Trends
For FY2023, Return on Capital Employed [ROCE] at Oruka Therapeutics came in at -18.32%, up 3.82 percentage points from FY2022.
- Return on Capital Employed [ROCE] shows a five-year change of +73.91 percentage points (FY2018 to FY2023).
- In earlier years, Return on Capital Employed [ROCE] was -22.13% in FY2022 (+17.18 pp), -39.32% in FY2021 (-1.73 pp), -37.59% in FY2020 (+48.49 pp) and -86.08% in FY2019 (+6.15 pp).
- The Q2 2024 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q3 2022.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in five of the last eight quarters, with an average year-over-year change of +6.66 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2019 (a gain of 64.30 percentage points); the worst was Q4 2021 (a drop of 15.29 percentage points).
- Per Business Quant data, ORKA's Return on Capital Employed [ROCE] in the three quarters before Q2 2024 was -22.36% (Q1 2024), -19.26% (Q4 2023) and -18.53% (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Oruka Therapeutics | 5.31 Bn | 3.37 Bn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -26.85% |
| Mar 31, 2024 | -22.36% |
| Dec 31, 2023 | -19.26% |
| Sep 30, 2023 | -18.53% |
| Jun 30, 2023 | -19.69% |
| Mar 31, 2023 | -22.07% |
| Dec 31, 2022 | -24.70% |
| Sep 30, 2022 | -33.03% |
| Jun 30, 2022 | -36.13% |
| Mar 31, 2022 | -36.84% |
| Dec 31, 2021 | -35.77% |
| Sep 30, 2021 | -31.52% |
| Jun 30, 2021 | -25.26% |
| Mar 31, 2021 | -22.01% |
| Dec 31, 2020 | -20.47% |
| Sep 30, 2020 | -19.54% |
| Jun 30, 2020 | -62.96% |
| Mar 31, 2020 | -78.51% |
| Dec 31, 2019 | -69.91% |
| Sep 30, 2019 | -67.23% |
Oruka Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();